Journal article

The ADP-ribose-1″-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses


Authors listKuri, T; Eriksson, KK; Putics, A; Züst, R; Snijder, EJ; Davidson, AD; Siddell, SG; Thiel, V; Ziebuhr, J; Weber, F

Publication year2011

Pages1899-1905

JournalJournal of General Virology

Volume number92

Issue number8

ISSN0022-1317

eISSN1465-2099

DOI Linkhttps://doi.org/10.1099/vir.0.031856-0

PublisherMicrobiology Society


Abstract

Several plus-strand RNA viruses encode proteins containing macrodomains. These domains possess ADP-ribose-1″-phosphatase (ADRP) activity and/or bind poly(ADP-ribose), poly(A) or poly(G). The relevance of these activities in the viral life cycle has not yet been resolved. Here, we report that genetically engineered mutants of severe acute respiratory syndrome coronavirus (SARS-CoV) and human coronavirus 229E (HCoV-229E) expressing ADRP-deficient macrodomains displayed an increased sensitivity to the antiviral effect of alpha interferon compared with their wild-type counterparts. The data suggest that macrodomain-associated ADRP activities may have a role in viral escape from the innate immune responses of the host.




Citation Styles

Harvard Citation styleKuri, T., Eriksson, K., Putics, A., Züst, R., Snijder, E., Davidson, A., et al. (2011) The ADP-ribose-1″-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses, Journal of General Virology, 92(8), pp. 1899-1905. https://doi.org/10.1099/vir.0.031856-0

APA Citation styleKuri, T., Eriksson, K., Putics, A., Züst, R., Snijder, E., Davidson, A., Siddell, S., Thiel, V., Ziebuhr, J., & Weber, F. (2011). The ADP-ribose-1″-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses. Journal of General Virology. 92(8), 1899-1905. https://doi.org/10.1099/vir.0.031856-0


Last updated on 2025-21-05 at 17:06